Topping out ceremony held at New Children’s Hospital

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
41
Topping out ceremony held at New Children’s Hospital

Espoo, Finland, 2017-03-30 13:00 CEST (GLOBE NEWSWIRE) -- SRV GROUP PLC                      PRESS RELEASE                                   30 MARCH 2017, AT 14.00

Topping out ceremony held at New Children’s Hospital

The construction of the New Children’s Hospital is progressing as planned, and the hospital has reached an important milestone – its topping out ceremony. The New Children’s Hospital’s topping out ceremony was held on Thursday, 30 March in Meilahti, Helsinki. The first half of the hospital will be completed for the installation of the user’s medical equipment in November 2017, and the rest of the hospital in June 2018. SRV is the project’s main contractor.

“The New Children’s Hospital is an excellent example of a challenging project in which open cooperation, careful advance planning and new solutions have helped achieve tight targets. Construction has gone well, and the project is progressing in accordance with set objectives, even though it has involved a tight schedule, overlapping planning and construction, and a restricted plot in the middle of a functioning hospital area,” says SRV’s Juha Toimela, Senior Vice President, Operations in Finland.

Excavation work began at the New Children’s Hospital in August 2014. Now an impressive façade covering, of which around one third has been completed, is being installed at the site. Inside the building, painting, tiling, floor covering and ceiling work, intermediate door and patient panel fittings as well as building systems work are under way.

“Particular successes to date have been the completion of the frame and the façade ahead of schedule from late summer 2016. With the selected implementation methods, the frame and the façade were quickly erected, enabling a faster start to be made on interior work, protected from the weather and moisture. The drying and quality of the structures has been measured and checked throughout construction,” says Site Manager Matti Julin .

Otherwise, the project has invested heavily in moisture and cleanliness management in order to achieve a safe and healthy work environment and end result, and tackling the shadow economy has also been an issue of particular focus. In addition, with an eye to the hospital’s future, the frame has been made flexible and adaptable, so that in the future interior spaces can be changed according to need. Currently, 265 people are working on the site. During the entire time of construction, a total around 3,000 people will work on the site.

The New Children’s Hospital will have eight floors above ground, a basement, and a machine room floor on the roof. The hospital will have within it a stunning 2,069 rooms, including 12 operating rooms, 16 intensive care units, 118 wards and 220 consultation or rehabilitation rooms.

SRV’s strong role as a hospital builder is reflected not only in the New Children’s Hospital, but also in other projects under way, such as the new building project in the front yard at TAYS Central Hospital in Tampere, Central Finland’s Hospital Nova in Jyväskylä, and the Kalasatama health and wellness centre in Helsinki. The total value of the several hospital and healthcare projects being built by SRV is currently EUR 650 million.

Further information:

Juha Toimela, SVP, Operations in Finland, +358 40 594 5473, juha.toimela@srv.fi Matti Julin, Site Manager, +358 40 070 4293, matti.julin@srv.fi  Päivi Kauhanen, SVP, Communications, +358 50 598 9560, paivi.kauhanen@srv.fi

www.srv.fi

You can also find us in the social media: Facebook    LinkedIn    Twitter    Instagram

SRV - Building for life

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Sojo Industries Partners with Molex to Enhance Supply Chain Tracking

Updated Category News Views 270

Sojo Industries Collaborates with Molex for Innovation Sojo Industries is making waves in the smart supply chain market with its latest collaboration with Molex. This partnership aims to elevate the production capabilities of the Sojo Seal™, an advanced device designed for tracking consumer-packaged goods. By enhancing supply chain transparency, this collaboration...

Continue Reading
Exploring the Driving Forces Behind Biodegradable Plastics Growth

Updated Category News Views 37

Understanding the Biodegradable Plastics Market As the world leans towards sustainability, the biodegradable plastics market is witnessing an impressive transformation. It is projected to reach USD 28.7 billion, showcasing a remarkable compound annual growth rate of 15.2% from 2024 to 2032. This shift is mainly driven by our collective concern over plastic waste and its...

Continue Reading
Securing Justice: ALLR Investors Unite for Legal Action

Updated Category News Views 50

Opportunity for Investors to Lead Legal Action Investors holding securities of Allarity Therapeutics, Inc. (NASDAQ: ALLR) now have a significant opportunity to join a legal action concerning alleged securities fraud. The Schall Law Firm, which represents investors in shareholder rights litigation, has announced a class action lawsuit aimed at seeking justice and recovery...

Continue Reading
Unlocking Monthly Income from HPQ Stock: A Guide

Updated Category News Views 134

Understanding HP Inc. and Its Dividend Potential HP Inc. (NYSE: HPQ) is on the verge of announcing its fourth-quarter earnings, generating buzz among investors. With analysts predicting earnings of approximately 92 cents per share, down slightly from 93 cents last year, the interest in HPQ is palpable. The expected quarterly revenue stands at a robust $14.49 billion, an...

Continue Reading
Upcoming Extraordinary General Meeting for RomReal: Key Details

Updated Category News Views 64

Overview of RomReal's Extraordinary General Meeting RomReal is gearing up for an Extraordinary General Meeting, which is important for both shareholders and potential investors. This gathering will provide stakeholders with a chance to engage with the company’s management and discuss its strategic path ahead. Purpose of the Extraordinary General Meeting The main goal of...

Continue Reading